Uncategorized

SonoThera bags $125M series B to advance safer gene therapies

SonoThera bags $125M series B to advance safer gene therapies

Published

on

Instead of using viral vectors, SonoThera’s genetic medicines are delivered through an ultrasound-mediated technology that could help sidestep key safety issues with conventional delivery methods.​ ​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version